KR940006583A - 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 - Google Patents
약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 Download PDFInfo
- Publication number
- KR940006583A KR940006583A KR1019930018067A KR930018067A KR940006583A KR 940006583 A KR940006583 A KR 940006583A KR 1019930018067 A KR1019930018067 A KR 1019930018067A KR 930018067 A KR930018067 A KR 930018067A KR 940006583 A KR940006583 A KR 940006583A
- Authority
- KR
- South Korea
- Prior art keywords
- adsorbents
- adsorbate
- nonsolid
- manufacture
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4230371 | 1992-09-11 | ||
| DEP4230371.0 | 1992-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR940006583A true KR940006583A (ko) | 1994-04-25 |
Family
ID=6467712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019930018067A Withdrawn KR940006583A (ko) | 1992-09-11 | 1993-09-09 | 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0587137A1 (enExample) |
| JP (1) | JPH06192093A (enExample) |
| KR (1) | KR940006583A (enExample) |
| AU (1) | AU663000B2 (enExample) |
| CA (1) | CA2105913A1 (enExample) |
| FI (1) | FI933954L (enExample) |
| HU (1) | HUT67577A (enExample) |
| IL (1) | IL106953A0 (enExample) |
| MX (1) | MX9305578A (enExample) |
| NO (1) | NO933237L (enExample) |
| NZ (1) | NZ248627A (enExample) |
| TW (1) | TW222585B (enExample) |
| ZA (1) | ZA936695B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0701434B1 (en) * | 1993-06-04 | 2002-08-07 | Warner-Lambert Company | Preparations containing silicon dioxide to improve the taste thereof |
| US5626878A (en) * | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| BR9916361A (pt) * | 1998-12-18 | 2002-11-05 | Abbott Lab | Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia |
| AU2005256322C1 (en) * | 2004-06-28 | 2011-07-07 | Veloxis Pharmaceuticals, Inc. | Porous tablets as carriers for liquid formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2879161A (en) * | 1956-05-14 | 1959-03-24 | American Cyanamid Co | Stable dry powder compositions containing choline chloride and methods of preparing same |
| DE3409063A1 (de) * | 1984-03-13 | 1985-09-19 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
-
1993
- 1993-03-02 TW TW082101487A patent/TW222585B/zh active
- 1993-09-08 EP EP93114413A patent/EP0587137A1/de not_active Withdrawn
- 1993-09-09 IL IL106953A patent/IL106953A0/xx unknown
- 1993-09-09 FI FI933954A patent/FI933954L/fi not_active Application Discontinuation
- 1993-09-09 HU HU9302555A patent/HUT67577A/hu unknown
- 1993-09-09 KR KR1019930018067A patent/KR940006583A/ko not_active Withdrawn
- 1993-09-09 NZ NZ248627A patent/NZ248627A/xx unknown
- 1993-09-10 AU AU46262/93A patent/AU663000B2/en not_active Ceased
- 1993-09-10 MX MX9305578A patent/MX9305578A/es not_active Application Discontinuation
- 1993-09-10 NO NO933237A patent/NO933237L/no unknown
- 1993-09-10 ZA ZA936695A patent/ZA936695B/xx unknown
- 1993-09-10 JP JP5225707A patent/JPH06192093A/ja active Pending
- 1993-09-10 CA CA002105913A patent/CA2105913A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW222585B (enExample) | 1994-04-21 |
| AU663000B2 (en) | 1995-09-21 |
| NZ248627A (en) | 1995-01-27 |
| JPH06192093A (ja) | 1994-07-12 |
| IL106953A0 (en) | 1993-12-28 |
| EP0587137A1 (de) | 1994-03-16 |
| AU4626293A (en) | 1994-03-17 |
| NO933237D0 (no) | 1993-09-10 |
| CA2105913A1 (en) | 1994-03-12 |
| ZA936695B (en) | 1994-04-05 |
| FI933954A7 (fi) | 1994-03-12 |
| HUT67577A (en) | 1995-04-28 |
| FI933954A0 (fi) | 1993-09-09 |
| HU9302555D0 (en) | 1993-11-29 |
| MX9305578A (es) | 1994-03-31 |
| NO933237L (no) | 1994-03-14 |
| FI933954L (fi) | 1994-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1523983T3 (da) | Vandig suspension indeholdende fenofibrat | |
| AU3567295A (en) | Pharmaceutical preparation containing metformin and a process for producing it | |
| CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
| BR9303993A (pt) | Composto, processo para preparar o mesmo e composição farmacêutica | |
| IL114210A0 (en) | Production of solid microspheres containing agriculturally active compounds | |
| EA200100203A1 (ru) | Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов | |
| EP0326357A3 (en) | Avermectin derivatives | |
| CA2390649A1 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | |
| FI925415A0 (fi) | Framstaellning av substituerade piperidiner | |
| WO2002050067A3 (en) | Pharmaceutical heterocyclic compounds | |
| KR940006583A (ko) | 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 | |
| JPS643040A (en) | Chemical admixture for cement | |
| PT1282617E (pt) | Derivados de hidantoína com afinidade para os receptores da somatostatina | |
| MEP88408A (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof | |
| WO2002060405A8 (en) | Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative | |
| CA2360894A1 (en) | (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| WO1999058527A3 (en) | Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| CA2326716A1 (en) | Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma | |
| HK47592A (en) | Piperazine derivatives | |
| DE69222143D1 (de) | Indanderivate | |
| WO2001083423A3 (en) | 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof | |
| KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
| JPS5282895A (en) | Fire-resistant mixture | |
| HK47492A (en) | Piperazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19930909 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |